The UK’s R&D budget for Health and Society remains stable from 2024 to 2027 at 0.15% of GDP, with a slight increase to 0.16% in 2028. This indicates a gradual focus shift towards potentially increasing investments in health and societal R&D, albeit at a slow rate.
The absence of earlier year-on-year variations suggests consistency in the budget allocation approach through 2024 to 2027, with a 6.67% increase between 2027 and 2028. The compound annual growth rate (CAGR) over this five-year period is modest, indicating limited resource allocation growth in this sector.
Future trends to watch for include how potential policy changes, economic conditions, or public health demands might further influence R&D spending, as well as shifts in prioritization within health and societal issues, which could redirect funding increases.
